Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?
- 31 March 2010
- journal article
- clinical trial
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 116 (3), 395-398
- https://doi.org/10.1016/j.ygyno.2009.12.008
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- The diagnostic value of PET/CT for primary ovarian cancer—A prospective studyGynecologic Oncology, 2007
- Carcinoma of the OvaryInternational Journal of Gynecology & Obstetrics, 2006
- PET/CT: will it change the way that we use CT in cancer imaging?Cancer Imaging, 2006
- Role of Docetaxel in the Treatment of Newly Diagnosed Advanced Ovarian CancerJournal of Clinical Oncology, 2003
- THE RISK-OF-MALIGNANCY INDEX TO EVALUATE POTENTIAL OVARIAN CANCERS IN LOCAL HOSPITALSObstetrics & Gynecology, 1999
- Stage IV Ovarian Cancer: Impact of Surgical Debulking1Gynecologic Oncology, 1997
- Effect of Surgical Debulking on Survival in Stage IV Ovarian CancerGynecologic Oncology, 1997
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958